Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Recent performance snapshot ...
RAPT Therapeutics, Inc. is a clinical-stage biotech developer of specific small molecules that can modulate the critical immune drivers of inflammatory diseases and oncology. The pipeline of ...
RAPT Therapeutics (RAPT) has drawn attention after a sharp move in its share price, with the stock showing strong gains over the past year and especially in the past 3 months. See our latest analysis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results